Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Jacobs syndrome 2Multiple Myeloma 1Genital Neoplasms, Female 1

Interventions

Cyclophosphamide 18fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 13Cyclosporine 12Whole-Body Irradiation 11Antilymphocyte Serum 10fludarabine 9Exercise 9Busulfan 9Mycophenolic Acid 8Melphalan 8Dexamethasone 8Blood Specimen Collection 8Filgrastim 7Standard of Care 6Radiotherapy 6Behavior Therapy 6Acupuncture Therapy 6Therapeutics 5Specimen Handling 5Palliative Care 5Methotrexate 5Granulocyte Colony-Stimulating Factor 5Etoposide 5Educational Status 5Surveys and Questionnaires 4Stem Cell Transplantation 4Psychiatric Rehabilitation 4Practice Guidelines as Topic 4Methylprednisolone 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Multiple Myeloma × Thrombopoietin × Clear all
NCT02572596 2017-02-09

Comparing Intermediate-dose CTX+ G-CSF Plus or Not rhTPO for PB CD34+ Cells Mobilization in MM Patients

Beijing Chao Yang Hospital

Phase NA Unknown
200 enrolled
Plasma cell

Jacobs syndrome, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡